• About us
• Contact

Advertisement

Organisation › Details

NewLink Genetics Corporation (Nasdaq: NLNK)

NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat cancer. Indoximod is being evaluated in combination with treatment regimens including anti-PD-1 agents, cancer vaccines, and chemotherapy across multiple indications such as melanoma, prostate cancer, acute myeloid leukemia, and pancreatic cancer. *

 

	Start	1999-01-01 established
	Industry	cancer immunotherapy (immuno-oncology, I-O)
	Industry 2	IDO inhibitor
	Person	Link, Charles J., jr. (NewLink Genetics 201706 CEO)
	Street	2503 South Loop Drive Suite 5100
	City	50010 Ames, IA
	Tel	+1-515-296-5555
		Address record changed: 2020-12-02
Basic data	Employees	C: 51 to 100 (2014-10-20)
		* Document for »About Section«: NewLink Genetics Corporation. (6/8/17). "Press Release: NewLink Genetics to Regain Rights to GDC-0919". Ames, IA.
		Record changed: 2023-07-10

Advertisement

More documents for NewLink Genetics Corporation (Nasdaq: NLNK)

• [1] NewLink Genetics Corporation. (6/8/17). "Press Release: NewLink Genetics to Regain Rights to GDC-0919". Ames, IA....
• [2] Cevec Pharmaceuticals GmbH. (2/9/17). "Press Release: Cevec Licenses CAP Technologies for the Development and Commercialization of Vaccines against Zika Virus Infections". Cologne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.